Representing clients ranging from start-ups to established global corporations, as well as private equity, venture capital, and investment banking firms, our Life Sciences team leverages in-depth knowledge of the life sciences industry to identify and resolve potential issues that may arise or regulations that may impact transactions.<\/p>\n\n\n\n
Advising at the national, regional, and local levels, we assist clients on the full range of corporate and transactional services including joint ventures, mergers and acquisitions, contracts and agreements, financing, regulatory matters, due diligence compliance reviews, board structure, corporate governance and federal government contracting matters. We also function as de facto general counsel for several clients in which we draft, negotiate, and review various commercial contracts relevant to our clients\u2019 businesses.<\/p>\n\n\n\n
We handle a variety of life science contracting matters for our clients, including licensing, acquisitions and other affiliations, joint ventures, co-promote and co-development, marketing and promotion, supply and distribution, clinical trial, investigator-initiated, material transfer, tech transfer, NIH grants, federal contracts, pharmacy benefit management services, specialty pharmacy, management services, consulting, speaker, scientific advisory board, grants and sponsorships, and charitable donations.<\/p>\n\n\n\n
We also advise manufacturers, investment banks, private equity and venture capital firms, and individual investors regarding transactions involving life sciences companies, including conducting regulatory due diligence reviews to identify and assess risks associated with target companies. We utilize our experience and knowledge of the FDA, FTC, and other regulatory requirements to perform risk assessments on regulatory processes affecting product approval, evaluate commercialization and post-approval activities, assess litigation risk in product liability actions, and provide input on the regulatory issues presented in financial disclosures and other transaction documents. When necessary, we also prepare transactional filings and notices to satisfy regulatory requirements applicable to a transaction.<\/p>\n","protected":false},"excerpt":{"rendered":"
Representing clients ranging from start-ups to established global corporations, as well as private equity, venture capital, and investment banking firms, our Life Sciences team leverages in-depth knowledge of the life sciences industry to identify and resolve potential issues that may arise or regulations that may impact transactions. Advising at the national, regional, and local levels, we\u2026<\/p>\n","protected":false},"author":19,"featured_media":0,"parent":0,"menu_order":0,"template":"single-industries-child","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"tags":[],"class_list":["post-61445","industries","type-industries","status-publish","format-standard","hentry"],"acf":[],"yoast_head":"\n